Bausch + Lomb and the Glaucoma Research Foundation (GRF) have partnered for the second annual Faces ...

Bausch + Lomb has announced the acquisition of Whitecap Biosciences, LLC, a biotechnology company de...

InflammX Therapeutics, Inc. has announced an option agreement with Bausch + Lomb, granting the latte...

This study, which played a crucial role in securing U.S. FDA approval for the device in January 2024...

Bausch + Lomb has announced that it has no immediate plans to go private, following an evaluation of...

Bausch + Lomb has unveiled the results of a pivotal clinical study published in Frontiers in Ophthal...

Bausch + Lomb has received the FDA approval for the Teneo Excimer Laser Platform for laser-assisted ...

Bausch + Lomb has announced that it will acquire the dry eye drug Xiidra (lifitegrast ophthalmic sol...

Bausch + Lomb announced that one of its affiliates has completed the purchase of the Blink® product ...

Through its exclusive recycling initiatives, Bausch + Lomb has collected 94,119,275 units of used co...